Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

United Therapeutics Corporation (UTHR)

-NasdaqGS
89.51 Down 1.43(1.57%) Aug 1, 4:00PM EDT
|After Hours : 89.51 0.00 (0.00%) Aug 1, 5:24PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 289,403   289,017   302,225   280,606  
Cost of Revenue30,600  38,778  30,716  32,320  
Gross Profit 258,803   250,239   271,509   248,286  
Operating Expenses
Research Development12,448  121,552  72,749  54,617  
Selling General and Administrative30,215  157,178  94,111  71,365  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 216,140   (28,491) 104,649   122,304  
Income from Continuing Operations
Total Other Income/Expenses Net1,686  1,423  951  854  
Earnings Before Interest And Taxes217,826  (27,068)105,719  123,039  
Interest Expense4,610  4,562  4,540  4,520  
Income Before Tax213,216  (31,630)101,179  118,519  
Income Tax Expense75,692  (1,316)38,494  38,655  
Minority Interest -   -   -   -  
Net Income From Continuing Ops137,524  (30,314)62,804  79,745  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 137,524   (30,314) 62,685   79,864  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 137,524   (30,314) 62,685   79,864  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.